The RNase H mechanism

Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition

Volumn , Issue , 2007, Pages 47-74

  Lima, Walt ^a   Wu, Hongjiang ^a   Crooke, Stanley T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057669819     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. Crooke, S. T. (1999) Molecular mechanisms of antisense drugs: human RNase H. Antisense Nucl. Acid Drug Dev. 9: 377-379.
2. Crooke, S. T. (2000) Progress in antisense technology: the end of the beginning. Methods Enzymol. 313: 3-45.
3. Crooke, S. T. (2001) In: Antisense Technology: Principles, Strategies and Applications. (Crooke, S. T., ed.) Marcel Dekker, New York, pp. 1-28.
4. Grishok, A., Tabara, H., and Mello, C. C. (2000) Genetic requirements for inheritance of RNAi in C. elegans. Science 287: 2494-2497.
5. Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33.
6. Stein, H. and Hausen, P. (1969) Enzyme from calf thymus degrading the RNA moiety of DNA-RNA hybrids: effect on DNA-dependent RNA polymerase. Science 166: 393-395.
7. Busen, W. (1980) Purification, subunit structure, and serological analysis of calf thymus ribonuclease HI. J. Biol. Chem. 255: 9434-9443.
8. Crouch, R. J. and Dirksen, M. L. (1982) In: Nucleases (Linn, S. M. and Roberts, R. J., eds.) Cold Spring Harbor. Cold Spring Harbor Press, Plainview, New York.
9. Kane, C. M. (1988) Renaturase and ribonuclease H: a novel mechanism that influences transcript displacement by RNA polymerase II in vitro. Biochemistry 27: 3187-3196.
10. Masutani, C., Enomoto, T., Suzuki, M., Hanaoka, F., and Ui, M. (1990) DNA primase stimulatory factor from mouse FM3A cells has an RNase H activity. Purification of the factor and analysis of the stimulation. J. Biol. Chem. 265: 10210-10216.
11. Eder, P. S. and Walder, J. A. (1991) Ribonuclease H from K562 human erythroleukemia cells. J. Biol. Chem. 266: 6472-6479.
12. Frank, P., Albert, S., Cazenave, C., and Toulme, J. J. (1994) Purification and characterization of human ribonuclease HII. Nucl. Acids Res. 22: 5247-5254.
13. 2′-dependent RNase HIII from Bacillus subtilis: classification of RNases H into three families. Biochemistry 38:605-618.
14. Kanaya, S., Kohara, A., Miura, Y., Sekiguchi, A., Iwai, S., Inoue, H., Ohtsuka, E., and Ikehara, M. (1990) Identification of the amino acid residues involved in an active site of Escherichia coli ribonuclease H by site-directed mutagenesis. J. Biol. Chem. 265: 4615-4621.
15. Katayanagi, K., Miyagawa, M., Matsushima, M., Ishikawa, M., Kanaya, S., Ikehara, M., Matsuzaki, T., and Morikawa, K. (1990) Three-dimensional structure of ribonuclease H from E. coli. Nature 347:306-309.
16. Kanaya, S., Katsuda-Nakai, C., and Ikebara, M. (1991) Importance of the positive charge cluster in Escherichia coli ribonuclease HI for the effective binding of the substrate. J. Biol. Chem. 266:11621-11627.
17. Nakamura, H., Oda, Y., Iwai, S., Inoue, H., Ohtsuka, E., Kanaya, S., Kimura, S., Katsuda, C., Katayanagi, K., Morikawa, K., Miyashiro, H., and Ikehara, M. (1991) How does RNase H recognize a DNA RNA hybrid? Proc. Natl. Acad. Sci. 88: 11535-11539.
18. Kanaya, S. (1998) Enzymic activity and protein stability of E. coli ribonuclease HI. Ribonucleases H. INSERM, Paris, pp. 1-38.
19. Kogoma, T. and Foster, P. L. (1998) Physiological functions of Escherichia coli RNase HI. Ribonucleases H. INSERM, Paris, pp. 39-66.
20. Yang, W. and Steitz, T. A. (1995) Recombining the structures of HIV integrase, RuvC and RNase H. Structure 3: 131-134.
21. Cerritelli, S. M. and Crouch, R. J. (1998) Cloning, expression, and mapping of ribonucleases H of human and mouse related to bacterial RNase HI. Genomics 53: 300-307.
22. Wu, H., Lima, W. F., and Crooke, S. T. (1998) Molecular cloning and expression of cDNA for human RNase H. Antisense Nucl. Acid Drug Dev. 8: 53-61.
23. Nowotany, N., Gaidamakov, S. A., Crouch, R. J. and Yang, W. (2005) Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis. Cell 121:1005-1016.
24. Hughes, S. H., Arnold, E., and Hostomsky, Z. (1998) RNase H of retroviral reverse transcriptases. Ribonucleases H. INSERM, Paris, pp. 195-224.
25. Frank, P., Braunshofer-Reiter, C., Wintersberger, U., Grimm, R., and Busen, W. (1998) Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII. Proc. Natl. Acad. Sci. 95: 12872-12877.
26. Wu, H., Lima, W. F., and Crooke, S. T. (1999) Properties of cloned and expressed human RNase H1. J. Biol. Chem. 274: 28270-28278.
27. Berkower, I., Leis, J., and Hurwitz, J. (1973) J. Biol. Chem. 248: 5914-5921.
28. Lima, W., Wu, H., Nichols, J. G., Manalili, S. M., Drader, J.J., Hofstadler, S.A., Crooke, S.T. (2003) Human RNase H1 activity is regulated by a unique redox switch formed between adjacent cysteins. J. Biol. Chem. 278: 14906-14912.
29. Wu, H., Lima, W. F., Crooke, S. T. (2001) Investigating the structure of human RNase H1 by sitedirected mutagenesis. J. Biol. Chem. 276: 23547-23553.
30. Cerritelli, S. M. and Crouch, R. J. (1995) The non-RNase H domain of Saccharomyces cerevisiae RNase H1 binds double-stranded RNA: magnesium modulates the switch between double-stranded RNA binding and RNase H activity. RNA 1: 246-259.
31. Evans, S. P. and Bycroft, M. (1999) NMR structure of the N-terminal domain of Saccharomyces cerevisiae RNase HI reveals a fold with a strong resemblance to the N-terminal domain of ribosomal protein L9. J. Mol. Biol. 291: 661-669.
32. Lima, W. F., Mohan, V., and Crooke, S. T. (1997) The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity. J. Biol. Chem. 272: 18191-18199.
33. Lima, W. F. and Crooke, S. T. (1997) Binding affinity and specificity of Escherichia coli RNase H1:impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry 36: 390-398.
34. Lima, W. F., Wu, H., and Crooke, S. T. (2001) In: Methods in Enzymology. Human RNases H. (Nicholson, A. W., ed.) Academic Press, San Diego, CA, pp. 430-440.
35. Lima, W. F., Nichols, J. G., Wu, H.-J., Prakash, T. P., Migawa, M. T., Wyrzykiewicz, T. K., Bhat, B., Crooke, S. T. (2004) Structural requirements at the catalytic site of the heteroduplex substrate for human RNase H1 catalysis. J. Biol. Chem. 279: 36317-36326.
36. Lima, W. F., Wu, H., Nichols, J., Prakash, T. P., Ravikumar, V., and Crooke, S. T. (2003) Human RNase H1 uses one tryptophan and two lysines to position the enzyme at the 3′-DNA/5′-RNA terminus of the heteroduplex substrate. J. Biol. Chem. 278: 49860-49867.
37. Hoffman, D. W., Cameron, C. S., Davies, C., White, S. W., and Ramakrishnan, V. (1996) Ribosomal protein L9: a structure determination by the combined use of X-ray crystallography and NMR spectroscopy. J. Mol. Biol. 264: 1058-1071.
38. Yang, W., Hendrickson, W. A., Crouch, R. J., and Satow, Y. (1990) Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein. Science 249:1398-1405.
39. Denisov, A. Y., Noronha, A. M., Wilds, C. J., Trempe, J.-F., Pon, R. T., Gehring, K., and Damha, M. (2001) Solution structure of an arabinonucleic acid (ANA)/RNA duplex in a chimeric hairpin: comparison with 2′-fluoro-ANA/RNA and DNA/RNA hybrids. Nucl. Acids Res. 29: 4284-4293.
40. Wu, H., Lima, W.F., Zhang, H., Fan, A., Sun, H., and Crooke, S.T. (2004) Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem. 279:17181-17189.
41. Cerritelli, S. M., Frolova, E. G., Feng, C., Grinberg, A., Love, P. E., and Crouch, R. J. (2003) Failure to produce mitochondrial DNA results in embryonic lethality in RNase H1 null mice. Mol. Cell 11:807-815.
42. Bambara, R. A., Murante, R. S., and Hendriksen, L. A. (1997) Enzymes and reactions at the eukaryotic DNA replication fork. J. Biol. Chem. 272: 4647-4650.
43. Lima, W. F., Rose, J. B., Nichols, J. G., Wu, H., Migawa, M. T., Wyrzykiewicz, T. K., Siwkowski, A. M., and Crooke, S. T. (2006) Human RNase H1 discriminates between subtle variations in the structure of the heteroduplex substrate. Mol. Pharmacol., 71: 83-91.
44. Jeong, H.-S., Backlund, P. S., Chen, H.-C., Karavanov, A. A., and Crouch, R. J. (2004) RNase H2 of Saccharomyces cerevisiae is a complex of three proteins. Nucl. Acid Res. 32: 407-414.
45. Lai, L., Yokota, H., Hung, L.-W., Kim, R., and Kim, S.-H. (2000) Crystal structure of archaeal RNase HII: a homologue of human major RNase H. Structure 8: 897-904.
46. Chapados, B. R., Chai, Q., Hosfield, D. J., Qiu, J., Shen, B., and Tainer, J. A. (2001) Structural biochemistry of a Type 2 RNase H: RNA primer recognition and removal during DNA replication. J. Mol. Biol. 307: 541-556.
47. Main, S. I. (1997) Comparative sequence analysis of ribonucleases HII, III, II, PH and D. Nucl. Acids Res. 25: 3187-3195.
48. Ohtani, N., Haruki, M., Morikowa, M., and Kanaya, S. (1999) Molecular diversity of RNases H. J. Biol. Chem. 88: 12-19.
49. Crooke, S. T. (2003) in Burger’s Medicinal Chemistry, 6th Edition. (Abraham, D. J., ed.) Vol. 5, Chapter 2, Wiley, New York, NY, pp. 115-166.
50. Vickers, T. A., Koo, S., Bennett, C. F., Crooke, S. T., Dean, N. M., and Baker, B. F. (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278: 7108-7118.
51. Crooke, S. T., Lemonidis, K. M., Neilson, L., Griffey, R., Lesnik, E. A., and Monia, B. P. (1995) Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes. Biochem. J. 312: 599-608.
52. Chiang, M.-Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., and Bennett, C. F. (1991) Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266: 18162-18171.
53. Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., Mcgee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., and Freier, S. M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268: 14514-14522.
54. Giles, R. V., Spiller, D. G., and Tidd, D. M. (1995) Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Res. Dev. 5: 23-31.
55. Monia, B. P. (1997) First-and second-generation antisense inhibitors targeted to human c-raf kinase:in vitro and in vivo studies. Anti-Cancer Drug Des. 12: 327-339.
56. Geary, R. S., Leeds, J. M., Fitchett, J., Burckin, T., Truong, L., Spainhour, C., Creek, M., and Levin, A. A. (1997) Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of c-raf-1 kinase expression. Drug Metab. Dispos. 25: 1272-1281.
57. Bost, F., McKay, R., Dean, N., and Mercola, D. (1997) The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272: 33422-33429.
58. Butler, M., Mckay, R., Popoff, I. J., Gaarde, W. A., Witchell, D., Murray, S. F., Dean, N. M., Bhanot, and S., Monia, B. P. (2002) Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51: 1028-1034.
59. Yacyshyn B. R., Bowen-Yacyshyn M. B., Jewell L., Tami J. A., Bennett C. F., Kisner D. L., and Shanahan W. R. (1998) A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn’s disease. Gastroenterology 6: 1133-1142.
60. Nishizaki, T., Iwai, S., Ohtsuka, E., Nakamura, H. (1997) Solution structure of an RNA 2′-O-methylated RNA hybrid duplex containing an RNA-DNA hybrid segment at the center. Biochemistry 36:2577-2585.
61. Lima, W. F., Rose, J. B., Nichols, J. G., Wu, H., Migawa, M. T., Wyrzykiewicz, T. K., Vasquez, G., Swayze, E. E., and Crooke, S. T. (2006) The positional influence of the helical geometry of the heteroduplex substrate on human RNase H1 catalysis. Mol. Pharmacol. 71: 73-82.